PCA
NEO icon

Private Capital Advisors’s NeoGenomics NEO Stock Holding History

Private Capital Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,300
Closed -$351K – 104
2021
Q4 		$351K Buy
+10,300
New +$403K 0.06% 65

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Private Capital Advisors's NEO Position: Q1 2022 in Review

Private Capital Advisors sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 10,300 shares — an estimated $351K sold.

Private Capital Advisors first reported a position in NEO in Q4 2021 and held it in 1 quarter. The position peaked at $351K in Q4 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Private Capital Advisors reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Private Capital Advisors sold 10,300 NeoGenomics shares in Q1 2022, an estimated $351K.
  • Private Capital Advisors first reported a position in NeoGenomics in Q4 2021 and held it in 1 quarter.
  • Private Capital Advisors's NeoGenomics position peaked at $351K in Q4 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Private Capital Advisors's 13F filing for Q1 2022, filed 22 Apr 2022.